Details of the Drug Reposition

General Information of This Drug (ID: DMY85QW)

Drug Name
Bazedoxifene   DMY85QW
Synonyms Brilence; Conbriza; Viviant; Bazedoxifene acetate; TSE-424; WAY-140424; WAY-TES 424
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hot flushes DISAX6J3 GA30 Approved [1]
Osteopetrosis DIS7GHNM LD24.10 Approved [2]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Postmenopausal osteoporosis DISS0RQZ FB83.11 Discontinued in Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Bazedoxifene FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7355).
3 Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma